World Journal of Stem Cells is published by Baishideng Publishing Group (BPG). Choosing BPG’s series of journals means placing compliance with scientific norms and ethical standards at the forefront.

World Journal of Stem Cells is a rigorously peer-reviewed, open-access academic journal dedicated to publishing original, high-quality research findings in the field of stem cells, including clinical, translational, and basic studies, as well as research involving artificial intelligence. The journal focuses on, but is not limited to, the following areas: Embryonic stem cells, germline stem cells, tissue-specific stem cells, adult stem cells, mesenchymal stromal cells, induced pluripotent stem cells, embryoid bodies, embryonal carcinoma stem cells, hemangioblasts, hematopoietic stem cells, lymphoid progenitor cells, myeloid progenitor cells, myoblasts (cardiac, skeletal, and smooth muscle), neoplastic stem cells, neural stem cells, other pluripotent stem cells, side-population cells, and totipotent stem cells. Types of articles published by the journal include clinical study, basic study, case report, editorial, review, minireview, systematic review, meta-analysis, guidelines, and correspondence.  The journal sincerely welcomes experts and scholars to submit original research manuscripts. Each submission will be reviewed by at least two independent referees, who will critically assess its novelty, significance, and reproducibility, as well as any flaws in experimental design and data processing, in order to provide authors with meaningful peer review reports. The journal adheres to editorial policies, peer-review processes, editorial processes, and publication ethics guidelines developed by the editorial office in accordance with the Committee on Publication Ethics, the International Committee of Medical Journal Editors, and the World Association of Medical Editors. By doing so, the journal strives to provide authors with high-quality services, offer readers high-quality academic content, and further advance clinical practice.

The 2025 edition of Journal Citation Reports® cites the 2024 journal impact factor (JIF) for WJSC as 3.6; JIF without journal self cites: 3.3; 5-year JIF: 4.4; JIF Rank: 14/32 in cell and tissue engineering; JIF Quartile: Q2; and 5-year JIF Quartile: Q2; JIF Rank: 100/204 in cell biology; JIF Quartile: Q2; and 5-year JIF Quartile: Q2.

The WJSC’s CiteScore for 2024 is 6.9 and Scopus CiteScore rank 2024: Histology is 13/61; Genetics is 97/348; Genetics (clinical) is 24/100; Molecular Biology is 152/410; Cell Biology is 122/285.

• Shengwen Calvin Li, PhD, Professor, (E-mail: choc.uci@gmail.com) Center for Neuroscience and Stem Cell Research, Children's Hospital of Orange County Children's Research Institute, Children's Hospital of Orange County, Neuroscience Institute, University of California Irvine, Orange, CA 92868, United States